These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 26095659)
1. Meropenem therapy in extracorporeal membrane oxygenation patients: an ongoing pharmacokinetic challenge. Honore PM; Jacobs R; Hendrickx I; De Waele E; Van Gorp V; Spapen HD Crit Care; 2015 Jun; 19(1):263. PubMed ID: 26095659 [No Abstract] [Full Text] [Related]
2. Antibiotics and extracorporeal circulation--one size does not fit all. Gonçalves-Pereira J; Oliveira B Crit Care; 2014 Dec; 18(6):695. PubMed ID: 25673035 [TBL] [Abstract][Full Text] [Related]
3. The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort study. Shekar K; Fraser JF; Taccone FS; Welch S; Wallis SC; Mullany DV; Lipman J; Roberts JA; Crit Care; 2014 Dec; 18(6):565. PubMed ID: 25636084 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic drug monitoring for meropenem after the extracorporeal membrane oxygenation circuit change in children: is it necessary? Di Nardo M; Cairoli S; Goffredo BM; Stoppa F; D'Argenio P; Corsetti T; Ranieri VM Minerva Anestesiol; 2016 Sep; 82(9):1018-9. PubMed ID: 27096330 [No Abstract] [Full Text] [Related]
5. Altered antibiotic pharmacokinetics during extracorporeal membrane oxygenation: cause for concern? Shekar K; Roberts JA; Ghassabian S; Mullany DV; Wallis SC; Smith MT; Fraser JF J Antimicrob Chemother; 2013 Mar; 68(3):726-7. PubMed ID: 23111850 [No Abstract] [Full Text] [Related]
6. Evaluation of Meropenem Pharmacokinetics in an Experimental Acute Respiratory Distress Syndrome (ARDS) Model during Extracorporeal Membrane Oxygenation (ECMO) by Using a PenP Andresen M; Araos J; Wong KY; Leung YC; So LY; Wong WT; Cabrera S; Silva C; Alegria L; Bruhn A; Soto D Sensors (Basel); 2018 May; 18(5):. PubMed ID: 29734646 [TBL] [Abstract][Full Text] [Related]
7. The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimens*. Jamal JA; Udy AA; Lipman J; Roberts JA Crit Care Med; 2014 Jul; 42(7):1640-50. PubMed ID: 24674926 [TBL] [Abstract][Full Text] [Related]
8. β-Lactam pharmacokinetics during extracorporeal membrane oxygenation therapy: A case-control study. Donadello K; Antonucci E; Cristallini S; Roberts JA; Beumier M; Scolletta S; Jacobs F; Rondelet B; de Backer D; Vincent JL; Taccone FS Int J Antimicrob Agents; 2015 Mar; 45(3):278-82. PubMed ID: 25542059 [TBL] [Abstract][Full Text] [Related]
9. Meropenem in children receiving continuous renal replacement therapy: clinical trial simulations using realistic covariates. Nehus EJ; Mouksassi S; Vinks AA; Goldstein S J Clin Pharmacol; 2014 Dec; 54(12):1421-8. PubMed ID: 25042683 [TBL] [Abstract][Full Text] [Related]
10. Are interstitial fluid concentrations of meropenem equivalent to plasma concentrations in critically ill patients receiving continuous renal replacement therapy? Varghese JM; Jarrett P; Wallis SC; Boots RJ; Kirkpatrick CM; Lipman J; Roberts JA J Antimicrob Chemother; 2015 Feb; 70(2):528-33. PubMed ID: 25336163 [TBL] [Abstract][Full Text] [Related]
11. Meropenem population pharmacokinetics in critically ill patients with septic shock and continuous renal replacement therapy: influence of residual diuresis on dose requirements. Ulldemolins M; Soy D; Llaurado-Serra M; Vaquer S; Castro P; Rodríguez AH; Pontes C; Calvo G; Torres A; Martín-Loeches I Antimicrob Agents Chemother; 2015 Sep; 59(9):5520-8. PubMed ID: 26124172 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of meropenem in children receiving continuous renal replacement therapy: Validation of clinical trial simulations. Nehus EJ; Mizuno T; Cox S; Goldstein SL; Vinks AA J Clin Pharmacol; 2016 Mar; 56(3):291-7. PubMed ID: 26222329 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of continuous-infusion meropenem in a pediatric patient receiving extracorporeal life support. Cies JJ; Moore WS; Dickerman MJ; Small C; Carella D; Chopra A; Parker J Pharmacotherapy; 2014 Oct; 34(10):e175-9. PubMed ID: 25146254 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of meropenem in patients with renal failure and patients receiving renal replacement therapy. Thalhammer F; Hörl WH Clin Pharmacokinet; 2000 Oct; 39(4):271-9. PubMed ID: 11069213 [TBL] [Abstract][Full Text] [Related]